XML 34 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Stockholders' Equity
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
Stockholders' Equity Stockholders’ Equity
Stock Incentive Plans
    The American Public Education, Inc. 2017 Omnibus Incentive Plan, or 2017 Incentive Plan, became effective on May 12, 2017, or the Effective Date. Upon effectiveness of the 2017 Incentive Plan, the Company ceased making awards under the American Public Education, Inc. 2011 Omnibus Incentive Plan, or the 2011 Incentive Plan. The 2017 Incentive Plan allows the Company to grant up to 1,675,000 shares, as well as shares of the Company’s common stock that were available for issuance under the 2011 Incentive Plan as of the Effective Date. In addition, the number of shares of common stock available under the 2017 Incentive Plan was increased from time to time by the number of shares subject to outstanding awards granted under the 2011 Incentive Plan that terminate by expiration, forfeiture, cancellation or otherwise without issuance of such shares following the Effective Date. On May 15, 2020, the Company’s stockholders approved an amendment to the 2017 Incentive Plan to increase the number of shares available for issuance thereunder by 1,425,000 and to extend the term of the 2017 Plan to May 15, 2030, as well as to clarify limitations on repricing. Grants under the 2017 Incentive Plan generally vest over a period of three years and the Company recognizes compensation expense over that period. The 2017 Incentive Plan includes a provision that allows individuals who have reached certain service and retirement eligibility criteria on the date of grant an accelerated service period of one year. The Company recognizes compensation expense for these individuals over the accelerated period. As of December 31, 2021, all shares subject to outstanding awards are under the 2017 Incentive Plan.

Restricted Stock and Restricted Stock Unit Awards

    The fair value of the Company’s restricted stock and restricted stock unit awards is calculated based on the closing price of the Company’s stock on the date of grant. The estimated fair value of these awards is recognized as stock-based compensation expense and is expensed over the vesting period using the straight-line method for Company employees and the graded-vesting method for members of the Board of Directors. The Company recognizes the estimated fair value of performance-based restricted stock units by assuming the satisfaction of any performance-based objectives at the “target” level, which is the most probable outcome determined for accounting purposes at the time of grant and multiplying the corresponding number of shares earned based upon such achievement by the closing price of the Company’s stock on the date of grant. To the extent performance goals are not met, compensation cost is not ultimately recognized against the goals and, to the extent previously recognized, compensation cost is reversed. The Company also estimates forfeitures of share-based awards at the time of grant and revises such estimates in subsequent periods if actual forfeitures differ from original estimates.
The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2019:

Number
of Shares		Weighted
Average Grant
Price and Fair Value
Non vested, December 31, 2018490,342 $24.23 
Shares granted333,635 29.48 
Vested shares(255,918)22.98 
Shares forfeited(21,119)26.86 
Non vested, December 31, 2019546,940 $27.81 

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2020:
Number
of Shares		Weighted
Average Grant
Price and Fair Value
Non vested, December 31, 2019546,940 $27.81 
Shares granted396,976 24.94 
Vested shares(307,937)26.95 
Shares forfeited(109,179)26.56 
Non vested, December 31, 2020526,800 $26.43 

The table below sets forth the restricted stock and restricted stock unit activity for the year ended December 31, 2021:
Number
of Shares		Weighted
Average Grant
Price and Fair Value
Non vested, December 31, 2020
526,800 $26.43 
Shares granted343,851 29.50 
Vested shares(268,329)26.66 
Shares forfeited(95,535)28.78 
Non vested, December 31, 2021
506,787 $27.68 

There were 37,738, 48,434, and 3,233 shares of restricted stock or restricted stock units excluded in the computation of diluted net income per common share for the years ended December 31, 2019, 2020, and 2021, respectively.
At December 31, 2021, total unrecognized compensation expense in the amount of $9.3 million relates to non-vested restricted stock, restricted stock units, and stock options, which will be recognized over a weighted average period of 1.7 years.
As a result of termination of employment, the Company accepted the following common shares for forfeiture: 17,825 shares for $488,974 in 2019, 73,808 shares for $1,855,784 in 2020, and 89,944 shares for $2,581,284 in 2021.
Option Awards
The fair value of each option award is estimated at the date of grant using a Black-Scholes option-pricing model. The Company makes assumptions with respect to expected stock price volatility based on the average historical volatility of the Company’s common stock. In addition, the Company determines the risk-free interest rate by selecting the U.S. Treasury constant maturity for the same maturity as the estimated life of the option, quoted on an investment basis in effect at the time of grant for that business day. Estimates of fair value are subjective and are not intended to predict actual future events, and
subsequent events are not necessarily indicative of the reasonableness of the original estimates of fair value made under FASB ASC Topic 718. Prior to 2012, the Company issued a mix of stock options and restricted stock, but ceased issuing options until 2019. Options currently outstanding vest ratably over a period of three years and expire in ten years from the date of grant.
The table below sets forth stock option activity for the year ended December 31, 2019:
Number
of Options		Weighted
Average Exercise
Price		Weighted
Average
Contractual
Life (years)		Aggregate
Intrinsic
Value
   (in thousands)
Outstanding, December 31, 2018— $— 
Options granted43,134 23.77 10
Awards exercised— — 
Options forfeited— — 
Outstanding, December 31, 201943,134 $23.77 9.73$156 
Exercisable, December 31, 2019— $— $— 

The table below sets forth stock option activity for the year ended December 31, 2020:
Number
of Options		Weighted
Average Exercise
Price		Weighted
Average
Contractual
Life (years)		Aggregate
Intrinsic
Value
   (in thousands)
Outstanding, December 31, 201943,134 $23.77 9.73$156 
Options granted17,370 33.11 10$— 
Awards exercised— — 
Options forfeited— — 
Outstanding, December 31, 202060,504 $26.45 8.96$264 
Exercisable, December 31, 202014,378 $23.77 8.73$88 
The table below sets forth stock option activity for the year ended December 31, 2021:
Number
of Options		Weighted
Average Exercise
Price		Weighted
Average
Contractual
Life (years)		Aggregate
Intrinsic
Value
   (in thousands)
Outstanding, December 31, 202060,504 $26.45 8.96$264 
Options granted51,230 27.72 10$— 
Awards exercised— —   
Options forfeited(10,214)30.83   
Outstanding, December 31, 2021101,520 $26.65 8.39$— 
Exercisable, December 31, 202134,547 $25.34 7.10$— 
The following table sets forth the assumptions used in calculating the fair value at the date of grant of each option award granted:
Year Ended December 31,
 201920202021
Expected volatility47.37 %48.74 %44.18 %
Expected dividends— %— %— %
Expected term, in years101010
Risk-free interest rate1.74 %0.68 %1.35 %
Weighted-average fair value of options granted during the year$13.91 $18.99 $15.13 
For the years ended December 31, 2019, 2020, and 2021, there were 43,134, 60,504, and 101,520 anti-dilutive stock options excluded from the calculation of diluted net income per share, respectively.
Stock-Based Compensation Expense
For the years ended December 31, 2019, 2020, and 2021, the Company recognized stock-based compensation expense as follows:
 Year Ended December 31,
 201920202021
 (In thousands)
Instructional costs and services$1,570 $1,535 $1,480 
Selling and promotional766 1,007 771 
General and administrative3,624 4,533 5,403 
Total stock-based compensation expense$5,960 $7,075 $7,654 
The Company recognized income tax benefits of $2.0 million, $1.9 million, and $2.3 million from vested restricted stock and restricted stock units for the years ended December 31, 2019, 2020, and 2021, respectively.
Repurchase
On December 9, 2011, the Company’s Board of Directors approved a stock repurchase program for our common stock, under which the Company could annually purchase up to the cumulative number of shares issued or deemed issued in that year under our equity incentive and stock purchase plans. Repurchases may be made from time to time in the open market at prevailing market prices or in privately negotiated transactions based on business and market conditions. The stock repurchase program does not obligate the Company to repurchase any shares, may be suspended or discontinued at any time, and is funded using our available cash.

On May 2, 2019, the Company’s Board of Directors authorized the repurchase of up to $35.0 million of the Company’s shares of common stock, and on December 5, 2019, the Board approved an additional authorization of up to $25.0 million of shares. Subject to market conditions, applicable legal requirements, and other factors, the repurchases may be made from time to time in the open market or in privately negotiated transactions. The authorization does not obligate the Company to acquire any shares, and purchases may be commenced or suspended at any time based on market conditions and other factors the Company deem appropriate. The Company may purchase shares at management’s discretion in the open market, in privately negotiated transactions, in transactions structured through investment banking institutions, or a combination of the foregoing. The Company may also, from time to time, enter into Rule 10b5-1 plans to facilitate repurchases of shares under this authorization. The amount and timing of repurchases are subject to a variety of factors, including liquidity, cash flow, stock price and general business and market conditions. The Company has no obligation to repurchase shares and may modify, suspend or discontinue the repurchase program at any time. The authorization under this program is in addition to the Company’s repurchase program under which the Company may annually purchase up to the cumulative number of shares issued or deemed issued in that year under our equity incentive and stock purchase plan.

During the years ended December 31, 2019 and 2020 the Company repurchased 1,416,304 and 547,563 shares of the Company’s common stock, respectively, for approximately $39.1 million and $13.6 million, respectively.
During the year ended December 31, 2021, the Company did not repurchase shares of common stock. As of December 31, 2021, the Company has remaining $8.4 million under its share repurchase authorization.

During the years ended December 31, 2019, 2020, and 2021, the Company was deemed to have repurchased 83,214, 78,847, and 99,469 shares, respectively, of common stock forfeited by employees to satisfy minimum tax-withholding requirements in connection with the vesting of restricted stock grants. These repurchases were not part of the stock repurchase programs authorized by our Board of Directors as described above.